Stock BIOSTEM TECHNOLOGIES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Biostem Technologies Inc Stock

Equities

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Biostem Technologies Inc
2023 NovaBay to Commercialize BioStem's Amniotic Tissue Allograft MT

Latest news about Biostem Technologies Inc

NovaBay to Commercialize BioStem's Amniotic Tissue Allograft MT
More news

Press releases Biostem Technologies Inc

BioStem Technologies to Present at the 2024 Planet MicroCap Showcase AQ
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange AQ
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference AQ
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase AQ
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024 AQ
More press releases

Managers and Directors - Biostem Technologies Inc

Managers TitleAgeSince
Andrew van Vurst FOU
 Founder - 06-07-06
Jason Matuszewski CEO
 Chief Executive Officer - 06-07-06
Michael Fortunato DFI
 Director of Finance/CFO - 20-12-31
Members of the board TitleAgeSince
Thomas Dugan CHM
 Chairman 66 Dec. 12
Patrick Daly BRD
 Director/Board Member - Dec. 18
Jason Matuszewski CEO
 Chief Executive Officer - 06-07-06
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+0.73% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-8.35% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock